Cargando…
The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
Amyloid-ß (Aß) is best known as the misfolded peptide that is involved in the pathogenesis of Alzheimer's disease (AD), and it is currently the primary therapeutic target in attempts to arrest the course of this disease. This notoriety has overshadowed evidence that Aß serves several important...
Autores principales: | Brothers, Holly M., Gosztyla, Maya L., Robinson, Stephen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996906/ https://www.ncbi.nlm.nih.gov/pubmed/29922148 http://dx.doi.org/10.3389/fnagi.2018.00118 |
Ejemplares similares
-
Consequences of redefining Alzheimer's disease in terms of amyloid burden without regard to cognitive decline
por: Robinson, Stephen R., et al.
Publicado: (2018) -
Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer’s Disease
por: Karisetty, Bhanu Chandra, et al.
Publicado: (2020) -
The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer’s Disease
por: Viola, Kirsten L., et al.
Publicado: (2022) -
β-Amyloid oligomers in aging and Alzheimer’s disease
por: Zahs, Kathleen R., et al.
Publicado: (2013) -
A review of β-amyloid neuroimaging in Alzheimer's disease
por: Adlard, Paul A., et al.
Publicado: (2014)